Member Exclusive

Is Banking of HLA-typed iPS Cell Lines for Cell-Based Therapy Practical, Sustainable and Commercially Feasible?

The first pilot clinical study of cell-based therapy using human induced pluripotent stem cell (iPSC) has started in Japan, and banking of HLA-typed iPSC lines is proposed for practical application of the iPSC-based therapy.

Please sign in or register for FREE

No comments yet.